Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous seum or fatal bovine serum

International Journal of Developmental Biology

Volumn 52, Issue 8, 2008, Pages 1033-1042

  Dahl, John Arne ^a   Duggal, Shivali ^b   Coulston, Neralie ^c   Millar, Douglas ^c   Melki, John ^c   Shahdadfar, Aboulghassem ^b   Brinchmann, Jan E ^b   Collas, Philippe ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c Human Genetic Signatures   (Australia)

Author keywords

Bisulfite sequencing; COBRA; Comparative genomic hybridization; Genomic stability

Indexed keywords

BISULFITE; BLOOM SYNDROME HELICASE; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; BREAST CANCER RESISTANCE PROTEIN; CXCL2 CHEMOKINE; DNA; LAMIN A; LAMIN B; MISMATCH REPAIR PROTEIN PMS2; NOTCH RECEPTOR; PROTEIN S 100; PROTEIN TYROSINE PHOSPHATASE; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR ELK 1; TRANSCRIPTION FACTOR JUNB; TRANSCRIPTION FACTOR PAX7; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR 3;

ADIPOSE TISSUE CELL; ADULT; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CELL SUBPOPULATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CULTURE MEDIUM; DNA METHYLATION; DONOR; EPIGENETICS; FEMALE; FETAL CALF SERUM; GENE DELETION; GENE MUTATION; GENETIC STABILITY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MALE; MESENCHYMAL STEM CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS; STEM CELL; TELOMERE; ADIPOCYTE; ADULT STEM CELL; ANIMAL; BONE MARROW CELL; CATTLE; CULTURE TECHNIQUE; CYTOLOGY; GENE DOSAGE; GENETIC EPIGENESIS; GENOMIC INSTABILITY; METABOLISM; SPECIES DIFFERENCE;

BOVINAE;

ADIPOCYTES; ADULT STEM CELLS; ANIMALS; BONE MARROW CELLS; CATTLE; CELL CULTURE TECHNIQUES; COMPARATIVE GENOMIC HYBRIDIZATION; CULTURE MEDIA; DNA METHYLATION; EPIGENESIS, GENETIC; GENE DOSAGE; GENOMIC INSTABILITY; HUMANS; MESENCHYMAL STEM CELLS; SPECIES SPECIFICITY;

EID: 61449505236     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.082663jd     Document Type: Article

References (57)

1. ALLEGRUCCI, C., WU, Y.Z., THURSTON, A., DENNING, C.N., PRIDDLE, H., MUMMERY, C.L., WARD-VAN, O.D., ANDREWS, P.W., STOJKOVIC, M., SMITH, N., PARKIN, T., JONES, M.E., WARREN, G., YU, L., BRENA, R.M., PLASS, C. and YOUNG, L.E. (2007). Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome. Hum. Mol. Genet. 16: 1253-1268.
2. ANTEQUERA, F. (2003). Structure, function and evolution of CpG island promoters. Cell Mol. Life Sci. 60: 1647-1658.
3. BARKER, N. and CLEVERS, H. (2000). Catenins, Wnt signaling and cancer. BioEssays 22: 961-965.
4. BATTULA, V.L., BAREISS, P.M., TREML, S., CONRAD, S., ALBERT, I., HOJAK, S., ABELE, H., SCHEWE, B., JUST, L., SKUTELLA, T. and BUHRING, H.J. (2007). Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation 75: 279-291.
5. BERGER, M.G., VEYRAT-MASSON, R., RAPATEL, C., DESCAMPS, S., CHASSAGNE, J. and BOIRET-DUPRE, N. (2006). Cell culture medium composition and translational adult bone marrow-derived stem cell research. Stem Cells 24: 2888-2890.
6. BERNARDO, M.E., AVANZINI, M.A., PEROTTI, C., COMETA, A.M., MORETTA, A., LENTA, E., DEL, F.C., NOVARA, F., DE, S.A., AMENDOLA, G., ZUFFARDI, O., MACCARIO, R. and LOCATELLI, F. (2007a). Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute. J. Cell Physiol. 211: 121-130.
7. BERNARDO, M.E., ZAFFARONI, N., NOVARA, F., COMETA, A.M., AVANZINI, M.A., MORETTA, A., MONTAGNA, D., MACCARIO, R., VILLA, R., DAIDONE, M.G., ZUFFARDI, O. and LOCATELLI, F. (2007b). Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res. 67: 9142-9149.
8. BIBIKOVA, M., CHUDIN, E., WU, B., ZHOU, L., GARCIA, E.W., LIU, Y., SHIN, S., PLAIA, T.W., AUERBACH, J.M., ARKING, D.E., GONZALEZ, R., CROOK, J., DAVIDSON, B., SCHULZ, T.C., ROBINS, A., KHANNA, A., SARTIPY, P., HYLLNER, J., VANGURI, P., SAVANT-BHONSALE, S., SMITH, A.K., CHAKRAVARTI, A., MAITRA, A., RAO, M., BARKER, D.L., LORING, J.F. and FAN, J.B. (2006). Human embryonic stem cells have a unique epigenetic signature. Genome Res. 16: 1075-1083.
9. BIRD, A. (2002). DNA methylation patterns and epigenetic memory. Genes Dev. 16: 6-21.
10. BOQUEST, A.C., NOER, A., SORENSEN, A.L., VEKTERUD, K. and COLLAS, P. (2007). CpG methylation profiles of endothelial cell-specific gene promoter regions in adipose tissue stem cells suggest limited differentiation potential toward the endothelial cell lineage. Stem Cells 25: 852-861.
11. BOQUEST, A.C., SHAHDADFAR, A., BRINCHMANN, J.E. and COLLAS, P. (2006). Isolation of stromal stem cells from human adipose tissue. Methods Mol. Biol. 325: 35-46.
12. BOQUEST, A.C., SHAHDADFAR, A., FRONSDAL, K., SIGURJONSSON, O., TUNHEIM, S.H., COLLAS, P. and BRINCHMANN, J.E. (2005). Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture. Mol. Biol. Cell. 16: 1131-1141.
13. BROOKE, G., COOK, M., BLAIR, C., HAN, R., HEAZLEWOOD, C., JONES, B., KAMBOURIS, M., KOLLAR, K., MCTAGGART, S., PELEKANOS, R., RICE, A., ROSSETTI, T. and ATKINSON, K. (2007). Therapeutic applications of mesenchymal stromal cells. Semin. Cell Dev. Biol. 18: 846-858.
14. BURNS, J.S., ABDALLAH, B.M., GULDBERG, P., RYGAARD, J., SCHRODER, H.D. and KASSEM, M. (2005). Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells. Cancer Res. 65: 3126-3135.
15. CHIDGEY, M. and DAWSON, C. (2007). Desmosomes: a role in cancer? Br. J. Cancer 96: 1783-1787.
16. CLARK, S.J., STATHAM, A., STIRZAKER, C., MOLLOY, P.L. and FROMMER, M. (2006). DNA methylation: bisulphite modification and analysis. Nat. Protoc. 1: 2353-2364.
17. FRASER, J.K., WULUR, I., ALFONSO, Z. and HEDRICK, M.H. (2006). Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol. 24: 150-154.
18. FREITAS, C.S. and DALMAU, S.R. (2006). Multiple sources of non-embryonic multipotent stem cells: processed lipoaspirates and dermis as promising alternatives to bone-marrow-derived cell therapies. Cell Tissue Res. 325: 403-411.
19. GRAFF, J.R., GABRIELSON, E., FUJII, H., BAYLIN, S.B. and HERMAN, J.G. (2000). Methylation patterns of the E-cadherin 5′ CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J. Biol. Chem. 275: 2727-2732.
20. HAYFLICK, L. (2003). Living forever and dying in the attempt. Exp. Gerontol. 38: 1231-1241.
21. JIANG, Y., VAESSEN, B., LENVIK, T., BLACKSTAD, M., REYES, M. and VERFAILLIE, C.M. (2002). Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp. Hematol. 30: 896-904.
22. JONES, P.A. and TAKAI, D. (2001). The role of DNA methylation in mammalian epigenetics. Science 293: 1068-1070.
23. KATZ, A.J., THOLPADY, A., THOLPADY, S.S., SHANG, H. and OGLE, R.C. (2005). Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hADAS) cells. Stem Cells 23: 412-423.
24. KERN, S., EICHLER, H., STOEVE, J., KLUTER, H. and BIEBACK, K. (2006). Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood or adipose tissue. Stem Cells 24: 1294-1301.
25. KOCAOEMER, A., KERN, S., KLUTER, H. and BIEBACK, K. (2007). Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 25: 1270-1278.
26. KUCIA, M., RECA, R., JALA, V.R., DAWN, B., RATAJCZAK, J. and RATAJCZAK, M.Z. (2005). Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells. Leukemia 19: 1118-1127.
27. KUME, T., TAGUCHI, R., KATSUKI, H., AKAO, M., SUGIMOTO, H., KANEKO, S. and AKAIKE, A. (2006). Serofendic acid, a neuroprotective substance derived from fetal calf serum, inhibits mitochondrial membrane depolarization and caspase-3 activation. Eur. J. Pharmacol. 542: 69-76.
28. KUNISAKI, S.M., ARMANT, M., KAO, G.S., STEVENSON, K., KIM, H. and FAUZA, D.O. (2007). Tissue engineering from human mesenchymal amniocytes: a prelude to clinical trials. J. Pediatr. Surg. 42: 974-979.
29. LAIRD, P.W. (2005). Cancer epigenetics. Hum. Mol. Genet. 14: R65-R76.
30. LANGE, C., CAKIROGLU, F., SPIESS, A.N., CAPPALLO-OBERMANN, H., DIERLAMM, J. and ZANDER, A.R. (2007). Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J. Cell Physiol. 213: 18-26.
31. LE BLANC K., FRASSONI, F., BALL, L., LOCATELLI, F., ROELOFS, H., LEWIS, I., LANINO, E., SUNDBERG, B., BERNARDO, M.E., REMBERGER, M., DINI, G., EGELER, R.M., BACIGALUPO, A., FIBBE, W. and RINGDEN, O. (2008). Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371: 1579-1586.
32. LE BLANC K. and RINGDEN, O. (2007). Immunomodulation by mesenchymal stem cells and clinical experience. J. Intern. Med. 262: 509-525.
33. LU, C. (2004). Improving the scaling normalization for high-density oligonucleotide GeneChip expression microarrays. BMC. Bioinformatics 5: 103-107.
34. MAITRA, A., ARKING, D.E., SHIVAPURKAR, N., IKEDA, M., STASTNY, V., KASSAUEI, K., SUI, G., CUTLER, D.J., LIU, Y., BRIMBLE, S.N., NOAKSSON, K., HYLLNER, J., SCHULZ, T.C., ZENG, X., FREED, W.J., CROOK, J., ABRAHAM, S., COLMAN, A., SARTIPY, P., MATSUI, S., CARPENTER, M., GAZDAR, A.F., RAO, M. and CHAKRAVARTI, A. (2005). Genomic alterations in cultured human embryonic stem cells. Nat. Genet. 37: 1099-1103.
35. MANNELLO, F. and TONTI, G.A. (2007). Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold! Stem Cells 25: 1603-1609.
36. MEZA-ZEPEDA, L.A., NOER, A., DAHL, J.A., MICCI, F., MYKLEBOST, O. and COLLAS, P. (2008). High-resolution analysis of genetic stability of human adipose tissue stem cells cultured to senescence. J. Cell. Mol. Med. 12: 553-563.
37. MIURA, Y., GAO, Z., MIURA, M., SEO, B.M., SONOYAMA, W., CHEN, W., GRONTHOS, S., ZHANG, L. and SHI, S. (2006). Mesenchymal stem cell-organized bone marrow elements: an alternative hematopoietic progenitor resource. Stem Cells 24: 2428-2436.
38. MOORE, H. (2006). The medium is the message. Nat. Biotechnol. 24: 160-161.
39. NOER, A., BOQUEST, A.C. and COLLAS, P. (2007). Dynamics of adipogenic promoter DNA methylation during clonal culture of human adipose stem cells to senescence. BMC. Cell Biol. 8: 18-29.
40. NOER, A., SØRENSEN, A.L., BOQUEST, A.C. and COLLAS, P. (2006). Stable CpG hypomethylation of adipogenic promoters in freshly isolated, cultured and differentiated mesenchymal stem cells from adipose tissue. Mol. Biol. Cell 17: 3543-3556.
41. OLSHEN, A.B., VENKATRAMAN, E.S., LUCITO, R. and WIGLER, M. (2004). Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5: 557-572.
42. PAN, H., GAO, F., PAPAGEORGIS, P., ABDOLMALEKY, H.M., FALLER, D.V. and THIAGALINGAM, S. (2007). Aberrant Activation of gamma-Catenin Promotes Genomic Instability and Oncogenic Effects during Tumor Progression. Cancer Biol. Ther. 6: 1638-1643.
43. PITTENGER, M.F., MACKAY, A.M., BECK, S.C., JAISWAL, R.K., DOUGLAS, R., MOSCA, J.D., MOORMAN, M.A., SIMONETTI, D.W., CRAIG, S. and MARSHAK, D.R. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
44. RETTIG, W.J., GARIN-CHESA, P., HEALEY, J.H., SU, S.L., JAFFE, E.A. and OLD, L.J. (1992). Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer. Proc. Natl. Acad. Sci USA89: 10832-10836.
45. RUBIO, D., GARCIA, S., DE LA, C.T., PAZ, M.F., LLOYD, A.C., BERNAD, A. and GARCIA-CASTRO, J. (2008a). Human mesenchymal stem cell transformation is associated with a mesenchymal-epithelial transition. Exp. Cell Res. 314: 691-698.
46. RUBIO, D., GARCIA, S., PAZ, M.F., DE LA, C.T., LOPEZ-FERNANDEZ, L.A., LLOYD, A.C., GARCIA-CASTRO, J. and BERNAD, A. (2008b). Molecular characterization of spontaneous mesenchymal stem cell transformation. PLoS. ONE. 3: e1398.
47. RUBIO, D., GARCIA-CASTRO, J., MARTIN, M.C., DE LA, F.R., CIGUDOSA, J.C., LLOYD, A.C. and BERNAD, A. (2005). Spontaneous human adult stem cell transformation. Cancer Res. 65: 3035-3039.
48. SCHALLMOSER, K., BARTMANN, C., ROHDE, E., REINISCH, A., KASHOFER, K., STADELMEYER, E., DREXLER, C., LANZER, G., LINKESCH, W. and STRUNK, D. (2007). Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 47: 1436-1446.
49. SHAHDADFAR, A., FRONSDAL, K., HAUG, T., REINHOLT, F.P. and BRINCHMANN, J.E. (2005). In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells 23: 1357-1366.
50. SHIRAS, A., CHETTIAR, S.T., SHEPAL, V., RAJENDRAN, G., PRASAD, G.R. and SHASTRY, P. (2007). Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma. Stem Cells 25: 1478-1489.
51. SOTIROPOULOU, P.A., PEREZ, S.A., SALAGIANNI, M., BAXEVANIS, C.N. and PAPAMICHAIL, M. (2006). Cell culture medium composition and translational adult bone marrow-derived stem cell research. Stem Cells 24: 1409-1410.
52. TOLAR, J., NAUTA, A.J., OSBORN, M.J., PANOSKALTSIS, M.A., MCELMURRY, R.T., BELL, S., XIA, L., ZHOU, N., RIDDLE, M., SCHROEDER, T.M., WESTENDORF, J.J., MCIVOR, R.S., HOGENDOORN, P.C., SZUHAI, K., OSETH, L., HIRSCH, B., YANT, S.R., KAY, M.A., PEISTER, A., PROCKOP, D.J., FIBBE, W.E. and BLAZAR, B.R. (2007). Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 25: 371-379.
53. TOMKOWICZ, B., RYBINSKI, K., FOLEY, B., EBEL, W., KLINE, B., ROUTHIER, E., SASS, P., NICOLAIDES, N.C., GRASSO, L. and ZHOU, Y. (2007). Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration. Proc. Natl. Acad. Sci USA 104: 17965-17970.
54. WORKMAN, C., JENSEN, L.J., JARMER, H., BERKA, R., GAUTIER, L., NIELSER, H.B., SAXILD, H.H., NIELSEN, C., BRUNAK, S. and KNUDSEN, S. (2002). A new non-linear normalization method for reducing variability in DNA microarray experiments. Genome Biol. 3: 48-55.
55. XIONG, Z. and LAIRD, P.W. (1997). COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res. 25: 2532-2534.
56. ZHANG, Z.X., GUAN, L.X., ZHANG, K., WANG, S., CAO, P.C., WANG, Y.H., WANG, Z. and DAI, L.J. (2007). Cytogenetic analysis of human bone marrow-derived mesenchymal stem cells passaged in vitro. Cell Biol. Int. 31: 645-648.
57. ZUK, P.A., ZHU, M., MIZUNO, H., HUANG, J., FUTRELL, J.W., KATZ, A.J., BENHAIM, P., LORENZ, H.P. and HEDRICK, M.H. (2001). Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 7: 211-228.